Haemonetics (HAE) Accounts Payables (2010 - 2026)

Haemonetics has reported Accounts Payables for 17 years, with the latest figure at $51.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 23.8% year-over-year to $51.1 million; the trailing twelve-month figure through Mar 2026 stood at $51.1 million (down 23.8% YoY), and the FY2026 full-year result was $51.1 million, down 23.8% from the prior year.
• Accounts Payables for Q1 2026 stood at $51.1 million, up from $48.7 million in the prior quarter.
• The five-year high for Accounts Payables was $80.2 million in Q3 2023, with the low at $46.0 million in Q2 2025.
• Average Accounts Payables over 5 years is $62.7 million, with a median of $62.3 million recorded in 2024.
• Year-over-year, Accounts Payables surged 36.73% in 2022 and tumbled 40.19% in 2025.
• Tracing HAE's Accounts Payables over 5 years: stood at $63.8 million in 2022, then retreated by 10.86% to $56.8 million in 2023, then rose by 10.81% to $63.0 million in 2024, then retreated by 22.7% to $48.7 million in 2025, then rose by 4.85% to $51.1 million in 2026.
• The last three Accounts Payables figures came in at $51.1 million (Q1 2026), $48.7 million (Q4 2025), and $61.7 million (Q3 2025), per Business Quant data.

Peer Comparison